Open access
Aug 2026
Brain single-cell transcriptome-informed Mendelian randomization identifies potential druggable therapeutic targets for Alzheimer's disease
A brain cell type-resolved genetic prioritization framework for AD is provided, nominating genetically supported candidate druggable targets and linking them to neurodegenerative and immune-related pathways.
Ren-Jun Huang, Li-Qing Guan, Yang Chen et al.
· Journal of Alzheimer's Disea... · 0 citations